Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Role of Ginkgo Biloba Extract in IUGR

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Assiut University

Maneno muhimu

Kikemikali

The use of herbal medicinal products is increasing enormously in recent years, mainly among women, who use them for the most varied purposes, such as in menstrual problems, menopausal symptoms, mood disturbances and to strengthen their bones. Most of these benefits are due to the flavonoids present in these products. These flavonoids have anticarcinogenic, antiviral, antioxidant and antiinflammatory activities, as well as being used in the treatment of osteoporosis, menopausal symptoms and cardiovascular diseases . Besides the benefits from the consumption of flavonoids, little is known about their safety and potentially harmful toxic effects, such as mutagenicity and genotoxicity which might occur if taken in large doses . Safety of Ginkgo biloba during pregnancy or lactation was not criticized in literature. Roasted and raw ginkgo seed were not reported in the evidence-based medicine literature as being either safe or contraindicated in pregnancy or lactation. A higher incidence of postpartum hemorrhage was reported in the literature when associated with a 3-month ingestion of Ginkgo Biloba extract. Flavonoids are components of Ginkgo biloba L. (Ginkgoaceae), a medicinal plant widely used by the population . G. biloba has its origin in China, Korea and Japan where its fruits and leaves have been used as food and medicine for a long time.
The extract of G. biloba (EGb) is composed of different terpene trilactones, i.e., ginkgolides A, B, C, J and bilobalide, many flavonol glycosides, biflavones and alkylphenols . The major flavonoids in the extract are kaempferol, quercetin and isorhamnetin] whose metabolites were found in the blood of rats and in human urine after oral administration of EGb. Due to its actions as an anti-inflammatory and antioxidant, EGb has been largely used in the treatment of Alzheimer's disease, pre-menstrual syndrome, cerebrovascular insufficiency and peripheral arterial occlusive disease . In folk medicine, EGb is used as a vermifuge, to induce labor, for the treatment of bronchitis, chronic rhinitis, chilblains, arthritis and edema . The aim of this study was to evaluate the effect of oral supplementation of Ginkgo Biloba extract on the fetal weight as well as feto-maternal blood flow in cases of intrauterine growth restriction.

Tarehe

Imethibitishwa Mwisho: 02/29/2016
Iliyowasilishwa Kwanza: 04/20/2015
Uandikishaji uliokadiriwa Uliwasilishwa: 04/22/2015
Iliyotumwa Kwanza: 04/23/2015
Sasisho la Mwisho Liliwasilishwa: 03/19/2016
Sasisho la Mwisho Lilichapishwa: 03/21/2016
Tarehe halisi ya kuanza kwa masomo: 04/30/2014
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 09/30/2015
Tarehe ya Kukamilisha Utafiti: 11/30/2015

Hali au ugonjwa

Intrauterine Growth Restriction (IUGR)

Uingiliaji / matibabu

Drug: Ginkgo Biloba Extract group

Other: Placebo group

Awamu

Awamu 2

Vikundi vya Arm

MkonoUingiliaji / matibabu
Active Comparator: Ginkgo Biloba Extract group
This group received Ginko Biloba, two tablets per day
Drug: Ginkgo Biloba Extract group
Placebo Comparator: Placebo group
This group received placebo two tablets per day .
Other: Placebo group

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 20 Years Kwa 20 Years
Jinsia Inastahiki KujifunzaFemale
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Pregnant women in their third trimester (28-30 weeks of gestation).

- Pregnant women whose pregnancy was complicated with intra uterine growth restriction (IUGR).

- Normal Doppler indices in uterine, umbilical and middle cerebral arteries at time of recruitment.

Exclusion Criteria:

- Multiple pregnancies,

- Hypertension,

- Fetal congenital anomalies,

- Previous history of congenital anomalies or chromosomal abnormalities.

- Diabetes Mellitus

- Premature pre-labor rupture of membranes

- Antepartum hemorrhage

Matokeo

Hatua za Matokeo ya Msingi

1. Fetal weight (gm) [one and half year]

Hatua za Matokeo ya Sekondari

1. Doppler blood flow changes in uterine arteries indices [one and half year]

2. Doppler blood flow changes in umbilical arteries indices [one and half year]

3. Doppler blood flow changes in middle cerebral artery indices [one and half year]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge